Skip to main content

Moderna reports early success in respiratory infection vaccine

In a clinical trial of 124 adult subjects, a single dose of the vaccine was linked to a three- to six-fold increase in virus-fighting antibodies, according to Moderna.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.